Stefanie Jennings
Family · Alexandria, VANPI 1790385706
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.
Across 74 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$220
- Lilly USA, LLC$177
- Pfizer$170
- AstraZeneca$113
- GSK$76
- Coala Life Inc$68
- plus $598 from 19 others
What the payments were for
- Food & beverage$1,422100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $220 |
| Lilly USA, LLC | 10 | $177 |
| Pfizer | 8 | $170 |
| AstraZeneca | 6 | $113 |
| GSK | 4 | $76 |
| Coala Life Inc | 1 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| AbbVie | 3 | $58 |
| QOL Medical, LLC | 2 | $52 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Astellas Pharma US Inc | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Exact Sciences | 2 | $40 |
| IBSA Pharma Inc. | 2 | $34 |
| Boehringer Ingelheim | 1 | $26 |
| Qorumpartners | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Bayer | 1 | $17 |
| Medtronic | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $11 |
How this compares
$1,422 in reported general payments places this provider in the 75th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 16 | $61 |
Paid to pharmacies, not to this prescriber.
Other family in Alexandria
- Kristin WulffAlexandria$18K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.